Out of 88 post-vaccination SARS-CoV-2 breakthrough infections, 90.91 per cent were symptomatic cases and the remaining 9.09 per cent were asymptomatic. Among symptomatic breakthrough infections, 31.25 per cent were mild,...
Subscribe to get complete access to Outlook Print and Digital Magazines, Web Exclusive stories and the Archive. Attractive gifts with each subscription.
